Ligand validation:8CQK

VYQ: (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-1-[2-methyl-4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide

VYQ is a Ligand Of Interest in 8CQK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8CQK_VYQ_L_301	48%	5%	0.206	0.95	4.06	1.41	16	6	0	0	100%	1
8CQK_VYQ_F_301	46%	5%	0.194	0.93	4.06	1.37	16	7	2	0	100%	1
8CQK_VYQ_C_301	45%	5%	0.21	0.942	4.04	1.39	17	6	1	0	100%	1
8CQK_VYQ_I_301	43%	5%	0.217	0.94	4.06	1.37	16	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.